Company
ChinaSuzhou Lixin Pharmaceutical Co. Ltd., Suzhou, China – FDA Inspections
Inspection records and compliance data for Suzhou Lixin Pharmaceutical Co. Ltd. in Suzhou. 2 FDA inspections on record, last inspected August 30, 2023.
Company Profile
This profile covers Suzhou Lixin Pharmaceutical Co. Ltd. based in Suzhou, China.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected March 13, 2015. Last inspected August 30, 2023.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 30, 2023 | VAI | Human Drugs · Drug Quality Assurance | 1259886 |
| March 13, 2015 | NAI | Human Drugs · Drug Quality Assurance | 918374 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Guangdong Blue Treasure Pharmaceuticals Co. Ltd.
Tien (Tianjin) Pharmaceutical Co., Ltd.
BrightGene Pharmaceutical Co., Ltd.
Esteve Huayi Pharmaceutical Co., Ltd.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Qingdao Jiulong Biopharmaceutical Co. Ltd.
Qilu Pharmaceutical Co., Ltd. (Laoling Site)
Shandong Lixin Pharmaceutical Co., Ltd.
NANJING HAIRUN PHARMACEUTICAL CO., LTD.
Taiho Pharmaceutical Co., Ltd.
Company Information
Name
Suzhou Lixin Pharmaceutical Co. Ltd.
FEI Number
3008251350
Address
21 Tangxi Road, Suzhou, China
Country
China
ID: 2ad0b1cc-f2ce-4670-9844-bde1417dd946